How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma?

Cancer Causes and Control

Volumn 18, Issue 2, 2007, Pages 135-142

  Diamond, Catherine ^a   Taylor, Thomas H ^a   Im, Theresa ^a   Wallace, Mark ^b   Saven, Alan ^c   Anton Culver, Hoda ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c SCRIPPS CLINIC   (United States)

Author keywords

AIDS; Epidemiologic methods; Lymphoma; Population surveillance

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; AGED; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHODGKIN LYMPHOMA; PREDICTION; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; VALIDATION PROCESS;

ADULT; CALIFORNIA; CASE-CONTROL STUDIES; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MALE; MANDATORY REPORTING; MEDICAL RECORDS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; REGISTRIES; SEER PROGRAM;

EID: 33846807243     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-006-0096-5     Document Type: Review

References (26)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338:853-860
2. State of California Department of Health Standards, Cancer Surveillance Section. California Cancer Registry Data Standards, Assessment Unit. Cancer Reporting in California: Abstracting and Coding Procedures for Hospitals. Volume One Fifth Edition May 1998
3. Seiffert JE, Price WT, Gordon B (1990) The California tumor registry: a state-of-the-art model for a regionalized, automated, population-based registry. Top Health Rec Manage 11:59-73
4. Diamond C, Taylor TH, Im T, Anton-Culver H (2006) Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS. Leuk Lymphoma 47:1822-1829
5. http://seer.cancer.gov/siterecode/
6. Percy C, Van Holten V, Muir C (eds) (1990) International Classification of Diseases for Oncology. England: World Health Organization, pp. xxxii-xxxvi
7. Fritz A, Ries L (eds) (1998) SEER Extent of Disease-1988 Codes and Coding Instructions. Bethesda, Maryland: Cancer Statistics Branch, National Institutes of Health, P. 180
8. http://seer.cancer.gov/registries/
9. American Hospital Association (2001) AHA Guide to the Health Care Field. Chicago, IL: Health Forum LLC
10. Zar JH (1984) Biostatistical Analysis. Englewood Cliffs, NJ: Prentice Hall, p. 378
11. Diamond C, Taylor TH, Aboumrad T, Anton-Culver H (2006) Changes in acquired immunodeficiency syndromerelated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. Cancer 106:128-135
12. Mocroft A, Katlama C, Johnson AM, et al (2000) AIDS across Europe, 1994-1998, the EuroSIDA Study. Lancet 356:291-296
13. Cote TR, O'Brien TR, Ward JW, Wilson SE, Blattner WA, National AIDS/Cancer Match Study Group (1995) AIDS and cancer registry linkage: measurement and enhancement of registry completeness. Prev Med 24:375-377
14. Cote TR, Biggar RJ, Rosenberg PS, et al (1997) Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation, and public health burden. Int J Cancer 73:645-650
15. Matthews GV, Bower M, Mandalia S, Powles T, Nelson MR, Gazzard BG (2000) Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood 96:2730-2734
16. Hooper WC, Holman RC, Clarke MJ, Chorba TL (2001) Trends in non-Hodgkin lymphoma (NHL) and HIV-associated NHL deaths in the United States. Am J Hematol 66:159-166
17. Clarke CA, Glaser SL (2004) Population-based surveillance of HIV-associated cancers: utility of cancer registry data. J Acquir Immune Defic Syndr 36:1083-1091
18. Department of Veteran's Affairs. Privacy and Release of Information, VHA handbook 1605.1. Washington DC, 2002
19. Anton-Culver H, Trejo R, Taylor TH, et al (2003) Cancer Incidence and Mortality in Orange County, 1996-2000. Irvine: Cancer Surveillance Program of Orange County/San Diego Imperial Organization for Cancer Control, Epidemiology Division, Department of Medicine, University of California, Irvine
20. Anton-Culver H, Trejo R, Taylor TH, et al (2003) Cancer Incidence and Mortality in San Diego County, 1996-2000. Irvine: Cancer Surveillance Program of Orange County/San Diego Imperial Organization for Cancer Control, Epidemiology Division, Department of Medicine. University of California, Irvine
21. Christian MC, Goldberg JL, Killen J, et al (2002) A central institutional review board for multi-institutional trials. N Engl J Med 346:1405-1408
22. Humphreys K, Trafton J, Wagner TH (2003) The cost of institutional review board procedures in multicenter observational research. Ann Intern Med 139:77
23. Annas GJ (2002) Medical privacy and medical research-judging the new federal regulations. N Engl J Med 346:216-220
24. Kulynych J, Korn D (2002) The effect of the new federal medical-privacy rule on research. N Engl J Med 346:201-204
25. Ingelfinger JR, Drazen JM (2004) Registry research and medical privacy. N Engl J Med 350:1452-1453
26. Holly EA, Gautam M, Bracci PM (2002) Comparison of interviewed and non-interviewed non-Hodgkin's lymphoma (NHL) patients in the San Francisco Bay Area. Ann Epidemiol 12:419-425